Skip to main content

Peer Review reports

From: Appropriate use of triazolam in elderly patients considering a quantitative benefit-risk assessment based on the pharmacokinetic-pharmacodynamic modeling and simulation approach supported by real-world data

Original Submission
30 May 2023 Submitted Original manuscript
22 Aug 2023 Reviewed Reviewer Report - Sang-In Park
27 Aug 2023 Reviewed Reviewer Report
4 Oct 2023 Author responded Author comments - Akira Okada
1 Nov 2023 Reviewed Reviewer Report
13 Dec 2023 Author responded Author comments - Akira Okada
Resubmission - Version 2
4 Oct 2023 Submitted Manuscript version 2
21 Jun 2024 Reviewed Reviewer Report
24 Jun 2024 Reviewed Reviewer Report
21 Jul 2024 Author responded Author comments - Akira Okada
Resubmission - Version 3
21 Jul 2024 Submitted Manuscript version 3
29 Jul 2024 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
7 Aug 2024 Editorially accepted
3 Sep 2024 Article published 10.1186/s40360-024-00777-z

You can find further information about peer review here.

Back to article page